US · ZSTK
ZeroStack Corp.
- Sector
- Financial Services · Asset Management
- Headquarters
- Toronto, ON M5H 3Y2
- Website
- zerostack.ai
Price · as of 2025-12-31
$5.19
Market cap 8.47M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $89.82 | +1,630.3% |
| Intrinsic Value(DCF) | $27.00 | +420.13% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | $1,318.20 | $1,568.57 | $0.00 | $0.00 | $0.00 |
| 2022 | $273.00 | $152.90 | $0.00 | $0.00 | $0.00 |
| 2023 | $42.51 | $82.95 | $1,970,999.41 | $0.00 | $0.00 |
| 2024 | $25.43 | $58.16 | $161.12 | $0.00 | $16.50 |
| 2025 | $7.22 | $89.82 | $43.35 |
AI valuation
Our deep-learning model estimates ZeroStack Corp.'s (ZSTK) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $89.82
- Current price
- $5.19
- AI upside
- +1,630.3%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$27.00
+420.13% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| ZSTK | ZeroStack Corp. | $5.19 | 8.47M | +1,630% | +420% | — | — | — | — | — | — | — | — | 43.35% | -30.74% | -30.52% | -11.79% | -7.29% | -5.66% | 0.76 | -101.30 | 1.01 | 0.74 | -12.40 | -10000.00% | -7563.00% | 7040.00% | — | -1.01 | -14.40% | — | 0.00% | — | — | — | — | — |
| AKAN | Akanda Corp. | $1.04 | 151.47K | +9,512% | +862% | — | +18,953% | -6.36 | 6.09 | 31.14 | -7.45 | — | 6.11 | 24.91% | -523.80% | -489.57% | -1830.03% | -998.53% | -48.90% | 0.08 | -43.78 | 1.39 | 1.28 | 1.15 | -9355.00% | -6127.00% | 30467.00% | -23.33% | -1.09 | -1384.96% | 0.00% | 0.00% | 28.41% | -5.15 | -3.71 | 26.97 | -7.37 |
| AMIX | Autonomix Medical, Inc. C… | $0.44 | 2.26M | — | — | — | — | -0.23 | 0.32 | — | 0.59 | — | 0.32 | 0.00% | — | — | -145.10% | 2283.35% | -118.77% | 0.00 | -65.84 | 5.63 | 5.35 | 0.83 | -6937.00% | — | 2407.00% | -316.49% | -4.84 | 1629.95% | 0.00% | 0.00% | 58.54% | 0.56 | 0.79 | — | -9.21 |
| ENSC | Ensysce Biosciences, Inc. | $0.62 | 1.48M | +2,572,138,798% | +223% | — | — | -1.10 | 2.36 | 1.68 | -0.83 | — | 2.36 | -38.57% | -129.17% | -153.30% | -471.83% | 16069.72% | -192.33% | 0.08 | -5.22 | 2.42 | 1.64 | 0.48 | -256.00% | 13353.00% | 6959834645.00% | -85550186.53% | -3399198.17 | 17914756446.99% | 3306.75% | -3630.90% | 3340.18% | -0.83 | 0.00 | 1.07 | -32.39 |
| KALA | KALA BIO, Inc. | $0.38 | 8.33M | — | — | — | — | -1.01 | 3.16 | — | -0.49 | — | 3.16 | 0.00% | — | — | -388.29% | 599.82% | -69.12% | 2.62 | -7.09 | 3.11 | 3.02 | 0.46 | -5977.00% | — | 369.00% | -76.03% | -1.73 | 433.08% | 0.00% | 0.00% | 11.20% | -0.49 | -0.68 | — | -17.97 |
| KZIA | Kazia Therapeutics Limite… | $8.45 | 13.69M | +90% | -63% | — | +12,468% | -0.63 | -1.56 | 309.03 | -0.68 | — | -1.38 | 100.00% | -33850.00% | -49290.48% | 226.03% | 112.59% | -149.76% | -0.05 | — | 0.35 | 0.32 | 0.30 | -6564.00% | -9818.00% | 3859.00% | -102.30% | -0.94 | 114.02% | 0.00% | 0.00% | 22.54% | -0.64 | -0.68 | 215.01 | -40.14 |
| MYNZ | Mainz Biomed B.V. | $0.76 | 3.11M | +29,917% | +195% | — | — | -0.25 | 0.90 | 6.08 | -0.13 | -0.02 | 1.79 | 64.31% | -2091.23% | -2421.80% | -465.82% | -559.63% | -151.15% | 0.54 | -17.39 | 1.32 | 1.08 | 0.15 | 128025.00% | -17.00% | -2724.00% | -319.32% | -2.87 | -519.21% | 0.00% | 0.00% | 61.01% | -0.13 | -0.14 | 2.76 | -13.59 |
| RDHL | RedHill Biopharma Ltd. | $0.97 | 3.23M | +40,100% | +30% | — | — | -0.94 | -1.66 | 0.97 | -0.46 | — | -0.76 | 60.31% | -181.69% | -102.80% | 632.60% | 242.32% | -40.24% | -0.08 | -265.69 | 0.54 | 0.37 | 0.56 | -11522.00% | 2317.00% | -7383.00% | -120.72% | -0.42 | 155.51% | 0.00% | 0.00% | 0.00% | -0.24 | -0.37 | 0.44 | -34.89 |
About ZeroStack Corp.
ZeroStack Corp. operates as an AI-powered asset management company focused on providing decentralized AI. ZeroStack is focused on providing exposure to decentralized AI through a concentrated digital asset approach structured to generate yield and fee-based income from staking validators, compute power technology companies, and complementary businesses within the $0G ecosystem and across the wider AI landscape.
- CEO
- Daniel Reis-Faria
- Employees
- 64
- Beta
- 1.93
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($27.00 ÷ $5.19) − 1 = +420.13% (DCF, example).